Neurogene Q1 EPS $(1.08), Inline

Benzinga · 05/09 11:38
Neurogene (NASDAQ:NGNE) reported quarterly losses of $(1.08) per share which met the analyst consensus estimate. This is a 8 percent decrease over losses of $(1.00) per share from the same period last year.